Francesco Porta Selected Research

Dihydropteridine Reductase (6,7 Dihydropteridine Reductase)

11/2016	Long-term safety and effectiveness of pramipexole in tetrahydrobiopterin deficiency.
4/2012	Dopamine agonists in dihydropteridine reductase deficiency.
3/2008	Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Porta Research Topics

Disease

16	Phenylketonurias (Phenylketonuria) 12/2020 - 03/2008
4	Methylmalonic acidemia 01/2022 - 07/2015
4	6-pyruvoyl-tetrahydropterin synthase deficiency 09/2020 - 03/2008
3	Glycogen Storage Disease Type II (Pompe's Disease) 12/2018 - 06/2013
2	Thyrotoxicosis 01/2022 - 01/2020
2	Medium chain acyl CoA dehydrogenase deficiency 01/2021 - 10/2012
2	Knee Osteoarthritis 01/2021 - 04/2012
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2019 - 10/2018
2	Coma (Comas) 10/2018 - 07/2015
2	Hypercholesterolemia 01/2018 - 02/2016
2	Parkinson Disease (Parkinson's Disease) 11/2016 - 05/2015
2	Disease Progression 07/2015 - 05/2015
2	Hyperammonemia 07/2015 - 03/2010
2	Intellectual Disability (Idiocy) 05/2015 - 03/2010
2	Systemic Scleroderma (Systemic Sclerosis) 08/2011 - 11/2010
2	Necrosis 11/2010 - 11/2010
1	Leukoencephalopathies 01/2022
1	Methylmalonic acidemia with homocystinuria 01/2022
1	Atypical Hemolytic Uremic Syndrome 01/2022
1	Hyperhomocysteinemia 01/2022
1	Leigh Disease (Leigh's Disease) 02/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Movement Disorders (Movement Disorder) 01/2021
1	Hypothyroidism 01/2020
1	Argininosuccinic Aciduria 01/2020
1	due to Sepiapterin Reductase Deficiency Dopa-Responsive Dystonia 01/2020
1	isovaleric Acidemia 02/2019
1	Muscle Weakness 12/2018
1	Maple Syrup Urine Disease 10/2018
1	Birth Weight (Birth Weights) 10/2018
1	Type B Niemann-Pick Disease 02/2018
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2018
1	succinic semialdehyde dehydrogenase deficiency 01/2018
1	Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset) 12/2017
1	Fabry Disease (Fabry's Disease) 01/2017
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2016
1	Gambling (Pathological Gambling) 11/2016
1	Acidosis 07/2015
1	Liver Failure 05/2015
1	Galactosemias (Galactosemia) 05/2015
1	Pain (Aches) 01/2014

Drug/Important Bio-Agent (IBA)

6	sapropterin (tetrahydrobiopterin)FDA Link 09/2020 - 03/2008
4	EnzymesIBA 01/2021 - 04/2011
4	Phenylalanine (L-Phenylalanine)FDA Link 12/2020 - 05/2008
4	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 09/2020 - 05/2008
4	Dopamine Agonists (Dopamine Agonist)IBA 11/2016 - 04/2012
3	Thyroid HormonesIBA 01/2022 - 01/2020
3	Amino Acids FDA Link 12/2020 - 01/2020
3	Levodopa (L Dopa)FDA LinkGeneric 11/2016 - 04/2012
3	Dihydropteridine Reductase (6,7 Dihydropteridine Reductase)IBA 11/2016 - 03/2008
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022 - 07/2015
2	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2021 - 10/2012
2	chitotriosidaseIBA 02/2018 - 01/2013
2	Pramipexole (Mirapex)FDA LinkGeneric 11/2016 - 04/2012
2	tetrahydropterinIBA 11/2016 - 04/2012
2	ProlactinIBA 01/2016 - 05/2015
2	Dopamine (Intropin)FDA LinkGeneric 05/2015 - 04/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2012 - 03/2010
1	Methionine (L-Methionine)FDA Link 01/2022
1	Thiamine (Aneurin)FDA Link 02/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 12/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2020
1	Biogenic Amines (Biogenic Amine)IBA 09/2020
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	3-methylbutyrylcarnitineIBA 02/2019
1	pivalic acidIBA 02/2019
1	pivaloylcarnitineIBA 02/2019
1	alpha-Glucosidases (Acid Maltase)IBA 11/2018
1	GlycogenIBA 11/2018
1	Urea (Carbamide)FDA LinkGeneric 10/2018
1	AmmoniaIBA 10/2018
1	Familial apoceruloplasmin deficiencyIBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	globotriaosylceramide (globotriosylceramide)IBA 01/2017
1	GlycosphingolipidsIBA 01/2017
1	GalactosidasesIBA 01/2017
1	globotriaosyl lysosphingolipidIBA 01/2017
1	rotigotine FDA Link 08/2016
1	Transaminases (Aminotransferases)IBA 02/2016
1	Alkaline PhosphataseIBA 02/2016
1	Ceruloplasmin (Ferroxidase)IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Methylmalonyl-CoA MutaseIBA 07/2015
1	UTP-Hexose-1-Phosphate Uridylyltransferase (UTP Hexose 1 Phosphate Uridylyltransferase)IBA 05/2015
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2015
1	Serotonin (5 Hydroxytryptamine)IBA 05/2015
1	Homovanillic AcidIBA 05/2015
1	Galactose (Galactopyranose)FDA LinkGeneric 05/2015

Therapy/Procedure

6	Therapeutics 12/2020 - 04/2010
4	Liver Transplantation 01/2020 - 07/2015
1	Enzyme Replacement Therapy 12/2018
1	Artificial Respiration (Mechanical Ventilation) 12/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2018
1	Hematopoietic Stem Cell Transplantation 02/2018
1	Secondary Prevention 12/2017
1	Aftercare (After-Treatment) 01/2014